Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SCN1A | P35498 | 1/20 | 0.33 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.33 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6491550 | 0.88 | NAMPT (0.34) | AGTR1LTB4R2 | |
| SCHEMBL6482436 | 0.85 | HDAC1 (0.40) | — | |
| SCHEMBL6493735 | 0.85 | SCN1A (0.35) | SCN1ASCN2ASCN3ACHRM3 | |
| SCHEMBL6481346 | 0.83 | MMP9 (0.43) | — | |
| SCHEMBL6480351 | 0.80 | CA2 (0.32) | AGTR1LTB4R2 | |
| SCHEMBL6496156 | 0.75 | GHSR (0.34) | AGTR1LTB4R2 | |
| SCHEMBL6481449 | 0.75 | F2 (0.39) | — | |
| SCHEMBL6482724 | 0.75 | MTTP (0.38) | — | |
| SCHEMBL6482717 | 0.75 | HDAC1 (0.41) | — | |
| SCHEMBL6492948 | 0.74 | BCHE (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | ELIXIR PHARMACEUTICALS, INC. | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | GLS2, STS, ABAT | SLC6A2 1969/4885SCN1A 494/4885SCN2A 634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.